Chevy Chase Trust’s VanEck Biotech ETF BBH Stock Holding History

Chevy Chase Trust’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,741	Closed	-$1.4M	–	638
2022 Q4	$1.4M	Buy	+8,741	New	+$1.38M	0.01%	569
2022 Q1	–	Sell	-13,769	Closed	-$2.61M	–	646
2021 Q4	$2.61M	Buy	+13,769	New	+$2.65M	0.01%	545

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Chevy Chase Trust's BBH Position: Q1 2023 in Review

Chevy Chase Trust sold out of VanEck Biotech ETF (BBH) in Q1 2023, closing a stake of 8,741 shares — an estimated $1.4M sold.

Chevy Chase Trust first reported a position in BBH in Q4 2021 and held it in 2 quarters. The position peaked at $2.61M in Q4 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2023.

Chevy Chase Trust reported no remaining VanEck Biotech ETF position as of Q1 2023 after selling out during the quarter.
Chevy Chase Trust sold 8,741 VanEck Biotech ETF shares in Q1 2023, an estimated $1.4M.
Chevy Chase Trust first reported a position in VanEck Biotech ETF in Q4 2021 and held it in 2 quarters.
Chevy Chase Trust's VanEck Biotech ETF position peaked at $2.61M in Q4 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2023.

Based on Chevy Chase Trust's 13F filing for Q1 2023, filed 16 May 2023.